Working to address equity in premature nutrition, National Black Nurses Association and Prolacta Bioscience support H.R. 7141
Type: Press Releases
Topic(s): Cost Savings / Cost Effectiveness Early Fortification Growth Product
Preterm infant study finds proactive use of Prolact CR cream improves growth and reduces NICU costs
Type: Press Releases
Topic(s): Cost Savings / Cost Effectiveness Early Fortification Growth Product
Prolacta Bioscience demonstrates leadership in human milk science with history of voluntarily reviewing health claims with the FDA
Type: Press Releases
Topic(s): Company
Human milk-based fortifiers cut mortality rate by 50% in preterm infants, independent study shows
Type: Press Releases
Topic(s): Clinical Studies Mortality
Study shows exclusive human milk diet benefits term infants post-gastroschisis repair; Data to be presented at ESPGHAN 2024 meeting
Type: Press Releases
Topic(s): Clinical Studies Conferences and Events
Pediatric Academic Societies Meeting includes symposium on cost-effectiveness of implementing exclusive human milk-based nutrition for premature infants
Type: Press Releases
Topic(s): Conferences and Events
Novel research illuminates breast milk’s unique contribution to COVID-19 defense in infants
Type: Press Releases
Topic(s): Conferences and Events
Real-world data on human milk-based fortification reveals limitations of protocol designs of two RCTs
Type: Press Releases
Topic(s): Company
Prolacta's human milk-based nutrition has touched the lives of 100,000 Premature and Critically Ill Infants Globally
Type: Press Releases
Topic(s): Company
Not finding the reference you’re looking for?
Use our main search field or email us at info@prolacta.com
